Correlation Between Biohaven Pharmaceutical and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Biohaven Pharmaceutical and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biohaven Pharmaceutical and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biohaven Pharmaceutical Holding and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Biohaven Pharmaceutical and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biohaven Pharmaceutical with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biohaven Pharmaceutical and Cadrenal Therapeutics,.
Diversification Opportunities for Biohaven Pharmaceutical and Cadrenal Therapeutics,
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biohaven and Cadrenal is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Biohaven Pharmaceutical Holdin and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Biohaven Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biohaven Pharmaceutical Holding are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Biohaven Pharmaceutical i.e., Biohaven Pharmaceutical and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Biohaven Pharmaceutical and Cadrenal Therapeutics,
Given the investment horizon of 90 days Biohaven Pharmaceutical Holding is expected to under-perform the Cadrenal Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Biohaven Pharmaceutical Holding is 2.18 times less risky than Cadrenal Therapeutics,. The stock trades about -0.15 of its potential returns per unit of risk. The Cadrenal Therapeutics, Common is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 1,509 in Cadrenal Therapeutics, Common on August 29, 2024 and sell it today you would lose (138.00) from holding Cadrenal Therapeutics, Common or give up 9.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biohaven Pharmaceutical Holdin vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Biohaven Pharmaceutical |
| Cadrenal Therapeutics, |
Biohaven Pharmaceutical and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biohaven Pharmaceutical and Cadrenal Therapeutics,
The main advantage of trading using opposite Biohaven Pharmaceutical and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biohaven Pharmaceutical position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
| Cadrenal Therapeutics, vs. Bright Minds Biosciences | Cadrenal Therapeutics, vs. HP Inc | Cadrenal Therapeutics, vs. Intel | Cadrenal Therapeutics, vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |